ACG Wealth’s Mustang Bio MBIO Stock Holding History

ACG Wealth’s Portfolio MBIO Stock Details MBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-33	Closed	-$83K	–	335
2021 Q1	$83K	Sell	33 -24	-42%	-$71.3K	0.01%	307
2020 Q4	$163K	Hold	57	–	–	0.02%	304
2020 Q3	$135K	Buy	+57	New	+$140K	0.02%	279

Other funds holding MBIO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ACG Wealth's MBIO Position: Q2 2021 in Review

ACG Wealth sold out of Mustang Bio (MBIO) in Q2 2021, closing a stake of 33 shares — an estimated $83K sold.

ACG Wealth first reported a position in MBIO in Q3 2020 and held it in 3 quarters. The position peaked at $163K in Q4 2020. 92 funds tracked by Wall St. Rank hold MBIO as of Q2 2021.

ACG Wealth reported no remaining Mustang Bio position as of Q2 2021 after selling out during the quarter.
ACG Wealth sold 33 Mustang Bio shares in Q2 2021, an estimated $83K.
ACG Wealth first reported a position in Mustang Bio in Q3 2020 and held it in 3 quarters.
ACG Wealth's Mustang Bio position peaked at $163K in Q4 2020.
92 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2021.

Based on ACG Wealth's 13F filing for Q2 2021, filed 6 Aug 2021.